To assess the impact of mTOR inhibition on cell growth we treated glioma cell lines with NVP-Bez235, INK-128, torin2, rapamycin (Figure 2a), erlotinib or PD153035 (Figure S4a). The gene discussed is MTOR; the disease is central nervous system cancer.